RAB0116

Human GRO-α / CXCL1 ELISA Kit

Name: Human GRO-α / CXCL1 ELISA Kit
Brand: SIGMA
Price: 2440 PLN

for serum, plasma, cell culture supernatant and urine

Slide 1 of 2

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

1 KIT

2440,00 zł

Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności

Informacje o tej pozycji

NACRES:

NA.32

UNSPSC Code:

41116158

Kluczowe dokumenty

Wyświetl całą dokumentację

Przejdź do

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

Nazwa produktu

Human GRO-α / CXCL1 ELISA Kit, for serum, plasma, cell culture supernatant and urine

species reactivity

human

packaging

kit of 96 wells (12 strips x 8 wells)

technique(s)

ELISA: suitable
capture ELISA: suitable

input

sample type plasma
sample type urine
sample type serum
sample type cell culture supernatant(s)

assay range

inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 2 pg/mL
standard curve range: 1.37-1000 pg/mL

detection method

colorimetric

shipped in

wet ice

storage temp.

−20°C

Gene Information

human ... CXCL1(2919)

Powiązane kategorie

Enzyme-Linked Immunosorbent Assay (ELISA) Kits

Immunoassay Platform Solutions

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 4

Ta pozycja	RAB0138	RAB0459	RAB0124
Sigma-Aldrich RAB0116 Human GRO-α / CXCL1 ELISA Kit	Sigma-Aldrich RAB0138 Human MIG / CXCL9 ELISA Kit	Sigma-Aldrich RAB0459 Human TGF-α ELISA Kit	Sigma-Aldrich RAB0124 Human SDF-1 β ELISA Kit
species reactivity human	species reactivity human	species reactivity human	species reactivity human
Gene Information human ... CXCL1(2919)	Gene Information human ... CXCL9(4283)	Gene Information human ... TGFA(7039)	Gene Information human ... CXCL12(6387)
assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 2 pg/mL standard curve range: 1.37-1000 pg/mL	assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 20 pg/mL standard curve range: 8.23-6000 pg/mL	assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 3 pg/mL standard curve range: 1.37-1000 pg/mL	assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 35 pg/mL standard curve range: 32.77-8000 pg/mL
input sample type plasma sample type urine sample type serum sample type cell culture supernatant(s)	input sample type cell culture supernatant(s) sample type serum sample type plasma sample type urine	input sample type cell culture supernatant(s) sample type serum sample type urine sample type plasma	input sample type plasma sample type urine sample type cell culture supernatant(s) sample type serum
technique(s) ELISA: suitable, capture ELISA: suitable	technique(s) ELISA: suitable, capture ELISA: suitable	technique(s) ELISA: suitable, capture ELISA: suitable	technique(s) ELISA: suitable, capture ELISA: suitable
shipped in wet ice	shipped in wet ice	shipped in wet ice	shipped in wet ice

Application

For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)

General description

The Human GRO-α (Growth Regulated Oncogene-α) ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme- linked immunosorbent assay for the quantitative measurement of human GRO-α in serum, plasma, cell culture supernatants and urine.

Immunogen

Recombinant Human GRO-α

Other Notes

A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.

Ta strona może zawierać tekst przetłumaczony maszynowo.

pictograms

GHS05

signalword

Warning

hcodes

H290

pcodes

P234 - P390

Hazard Classifications

Met. Corr. 1

Klasa składowania

8A - Combustible corrosive hazardous materials

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Wyszukaj dokument COA

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils.

Ziwei Zhou et al.

Frontiers in pharmacology, 13, 870178-870178 (2022-07-06)

The combination of immunotherapy with platinum-based chemotherapy has become the first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with negative driver gene mutations. However, finding an ideal chemotherapeutic regimen for immunotherapy and exploring the underlying mechanism have

The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.

Syed A Khurram et al.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 43(9), 667-674 (2014-06-27)

Chemokines regulate physiological and pathological leucocyte trafficking, and chemokine receptors play a role in tumorigenesis. Expression of interleukin-8 (IL-8) receptors CXCR1 and CXCR2 has been shown in oral squamous cell carcinoma (OSCC) but remains poorly characterised. This aim of this

Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

Dominika Nackiewicz et al.

Nephron. Experimental nephrology, 126(3), 141-147 (2014-05-24)

Lipoprotein abnormalities are associated with a rapid decline in renal function in patients of chronic kidney disease. In addition, hyperlipidemia is associated with an increased risk of developing renal insufficiency. The underlying molecular mechanisms for these clinical findings are unclear.

Selection of high-affinity Centyrin FN3 domains from a simple library diversified at a combination of strand and loop positions.

Michael D Diem et al.

Protein engineering, design & selection : PEDS, 27(10), 419-429 (2014-05-03)

Alternative scaffold molecules represent a class of proteins important to the study of protein design and mechanisms of protein-protein interactions, as well as for the development of therapeutic proteins. Here, we describe the generation of a library built upon the

Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.

Elvira L Liclican et al.

Cancer prevention research (Philadelphia, Pa.), 7(8), 845-855 (2014-06-11)

Understanding the molecular pathogenesis of lung cancer is necessary to identify biomarkers/targets specific to individual airway molecular profiles and to identify options for targeted chemoprevention. Herein, we identify mechanisms by which loss of microRNA (miRNA)125a-3p (miR125a) contributes to the malignant

Wyświetl wszystkie powiązane dokumenty

Powiązane treści

ELISA Kit Information

Instructions

User Guide-RAB0116

Questions

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej